vTv Therapeutics (VTVT) Interest Coverage Ratio Growth (3y) (2017 - 2025)
vTv Therapeutics (VTVT) Interest Coverage Ratio Growth (3y) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
29.25% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
-16.86% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
vTv Therapeutics |
426.76 Mn |
426.76 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-95.38% |
| Sep 30, 2025 |
-44.37% |
| Dec 31, 2023 |
-198.58% |
| Sep 30, 2023 |
-381.11% |
| Jun 30, 2023 |
-495.55% |
| Dec 31, 2022 |
-260.46% |
| Sep 30, 2022 |
-275.53% |
| Mar 31, 2022 |
-881.80% |
| Dec 31, 2021 |
-1,476.65% |
| Sep 30, 2021 |
-429.30% |
| Dec 31, 2020 |
56.35% |
| Sep 30, 2020 |
3.94% |
| Jun 30, 2020 |
-7.69% |
| Mar 31, 2020 |
-17.15% |
| Dec 31, 2019 |
12.51% |
| Jun 30, 2019 |
91.40% |
| Mar 31, 2019 |
89.96% |
| Dec 31, 2018 |
-27.37% |
| Sep 30, 2018 |
60.29% |
| Jun 30, 2018 |
-1.07% |
